|
US10083273B2
(en)
|
2005-07-29 |
2018-09-25 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US11111543B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US10081839B2
(en)
|
2005-07-29 |
2018-09-25 |
Natera, Inc |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US11111544B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US9424392B2
(en)
|
2005-11-26 |
2016-08-23 |
Natera, Inc. |
System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
|
|
EP3260556B1
(en)
|
2006-05-31 |
2019-07-31 |
Sequenom, Inc. |
Methods for the extraction of nucleic acid from a sample
|
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
|
CA2680588A1
(en)
|
2007-03-26 |
2008-10-02 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
|
US7888127B2
(en)
|
2008-01-15 |
2011-02-15 |
Sequenom, Inc. |
Methods for reducing adduct formation for mass spectrometry analysis
|
|
EP2276858A4
(en)
|
2008-03-26 |
2011-10-05 |
Sequenom Inc |
RESULTS IMPROVED BY POLYMORPHIC SEQUENCES IMPROVED BY RESTRICTION ENDUCLEASE
|
|
CA3116156C
(en)
|
2008-08-04 |
2023-08-08 |
Natera, Inc. |
Methods for allele calling and ploidy calling
|
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
|
CN102597266A
(en)
|
2009-09-30 |
2012-07-18 |
纳特拉公司 |
Methods for non-invasive prenatal ploidy calling
|
|
EP3088532B1
(en)
|
2009-12-22 |
2019-10-30 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
|
SG185544A1
(en)
*
|
2010-05-14 |
2012-12-28 |
Fluidigm Corp |
Nucleic acid isolation methods
|
|
US9677118B2
(en)
|
2014-04-21 |
2017-06-13 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US12545960B2
(en)
|
2010-05-18 |
2026-02-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11326208B2
(en)
|
2010-05-18 |
2022-05-10 |
Natera, Inc. |
Methods for nested PCR amplification of cell-free DNA
|
|
US11332793B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US10316362B2
(en)
|
2010-05-18 |
2019-06-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11339429B2
(en)
|
2010-05-18 |
2022-05-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US20190010543A1
(en)
|
2010-05-18 |
2019-01-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
CA3207599A1
(en)
|
2010-05-18 |
2011-11-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11332785B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11322224B2
(en)
|
2010-05-18 |
2022-05-03 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US11939634B2
(en)
|
2010-05-18 |
2024-03-26 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US12152275B2
(en)
|
2010-05-18 |
2024-11-26 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US12221653B2
(en)
|
2010-05-18 |
2025-02-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11408031B2
(en)
|
2010-05-18 |
2022-08-09 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
|
RU2620959C2
(en)
|
2010-12-22 |
2017-05-30 |
Натера, Инк. |
Methods of noninvasive prenatal paternity determination
|
|
JP6153874B2
(en)
|
2011-02-09 |
2017-06-28 |
ナテラ, インコーポレイテッド |
Method for non-invasive prenatal ploidy calls
|
|
US20140235474A1
(en)
|
2011-06-24 |
2014-08-21 |
Sequenom, Inc. |
Methods and processes for non invasive assessment of a genetic variation
|
|
US10196681B2
(en)
|
2011-10-06 |
2019-02-05 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US10424394B2
(en)
|
2011-10-06 |
2019-09-24 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
WO2013052907A2
(en)
|
2011-10-06 |
2013-04-11 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US9984198B2
(en)
|
2011-10-06 |
2018-05-29 |
Sequenom, Inc. |
Reducing sequence read count error in assessment of complex genetic variations
|
|
ES2886508T3
(en)
|
2011-10-06 |
2021-12-20 |
Sequenom Inc |
Methods and procedures for the non-invasive evaluation of genetic variations
|
|
US8688388B2
(en)
|
2011-10-11 |
2014-04-01 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
EP3243908B1
(en)
|
2011-10-11 |
2019-01-02 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
CA2861856C
(en)
|
2012-01-20 |
2020-06-02 |
Sequenom, Inc. |
Diagnostic processes that factor experimental conditions
|
|
US9605313B2
(en)
|
2012-03-02 |
2017-03-28 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
|
ES2902401T3
(en)
|
2012-05-21 |
2022-03-28 |
Sequenom Inc |
Methods and processes for the non-invasive evaluation of genetic variations
|
|
US10504613B2
(en)
|
2012-12-20 |
2019-12-10 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US10497461B2
(en)
|
2012-06-22 |
2019-12-03 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
HK1206792A1
(en)
|
2012-07-13 |
2016-01-15 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
|
AU2012385961B9
(en)
*
|
2012-07-24 |
2017-05-18 |
Natera, Inc. |
Highly multiplex PCR methods and compositions
|
|
US20140100126A1
(en)
|
2012-08-17 |
2014-04-10 |
Natera, Inc. |
Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
|
|
US10482994B2
(en)
|
2012-10-04 |
2019-11-19 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
EP2904534B1
(en)
|
2012-10-04 |
2021-12-15 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US20130309666A1
(en)
|
2013-01-25 |
2013-11-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US20130189684A1
(en)
|
2013-03-12 |
2013-07-25 |
Sequenom, Inc. |
Quantification of cell-specific nucleic acid markers
|
|
EP3597774A1
(en)
|
2013-03-13 |
2020-01-22 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
|
US9305756B2
(en)
|
2013-03-13 |
2016-04-05 |
Agena Bioscience, Inc. |
Preparation enhancements and methods of use for MALDI mass spectrometry
|
|
HUE061261T2
(en)
|
2013-04-03 |
2023-05-28 |
Sequenom Inc |
Methods and processes for non-invasive assessment of genetic variations
|
|
IL309903A
(en)
|
2013-05-24 |
2024-03-01 |
Sequenom Inc |
Methods and processes for non-invasive evaluation of genetic variations
|
|
ES3037160T3
(en)
|
2013-06-21 |
2025-09-29 |
Sequenom Inc |
Methods and processes for non-invasive assessment of genetic variations
|
|
US10577655B2
(en)
|
2013-09-27 |
2020-03-03 |
Natera, Inc. |
Cell free DNA diagnostic testing standards
|
|
US9499870B2
(en)
|
2013-09-27 |
2016-11-22 |
Natera, Inc. |
Cell free DNA diagnostic testing standards
|
|
US10262755B2
(en)
|
2014-04-21 |
2019-04-16 |
Natera, Inc. |
Detecting cancer mutations and aneuploidy in chromosomal segments
|
|
DK3053071T3
(en)
|
2013-10-04 |
2024-01-22 |
Sequenom Inc |
METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS
|
|
CA2925111C
(en)
|
2013-10-07 |
2024-01-16 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of chromosome alterations
|
|
US11365447B2
(en)
|
2014-03-13 |
2022-06-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
WO2015159979A1
(en)
*
|
2014-04-18 |
2015-10-22 |
凸版印刷株式会社 |
Method for recovering short-chain nucleic acids
|
|
US12492429B2
(en)
|
2014-04-21 |
2025-12-09 |
Natera, Inc. |
Detecting mutations and ploidy in chromosomal segments
|
|
EP3957749A1
(en)
|
2014-04-21 |
2022-02-23 |
Natera, Inc. |
Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
|
|
CA3191504A1
(en)
|
2014-05-30 |
2015-12-03 |
Sequenom, Inc. |
Chromosome representation determinations
|
|
US20180173846A1
(en)
|
2014-06-05 |
2018-06-21 |
Natera, Inc. |
Systems and Methods for Detection of Aneuploidy
|
|
ES3047391T3
(en)
|
2014-07-30 |
2025-12-03 |
Sequenom Inc |
Methods and processes for non-invasive assessment of genetic variations
|
|
EP3730629A1
(en)
|
2014-10-10 |
2020-10-28 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
EP4428863A3
(en)
|
2015-05-11 |
2024-12-11 |
Natera, Inc. |
Methods and compositions for determining ploidy
|
|
CN109477138A
(en)
|
2016-04-15 |
2019-03-15 |
纳特拉公司 |
Lung cancer detection method
|
|
EP3464626B1
(en)
|
2016-05-27 |
2022-04-06 |
Sequenom, Inc. |
Methods for detecting genetic variations
|
|
US11299780B2
(en)
|
2016-07-15 |
2022-04-12 |
The Regents Of The University Of California |
Methods of producing nucleic acid libraries
|
|
WO2018022890A1
(en)
|
2016-07-27 |
2018-02-01 |
Sequenom, Inc. |
Genetic copy number alteration classifications
|
|
CA3030894A1
(en)
|
2016-07-27 |
2018-02-01 |
Sequenom, Inc. |
Methods for non-invasive assessment of genomic instability
|
|
US11485996B2
(en)
|
2016-10-04 |
2022-11-01 |
Natera, Inc. |
Methods for characterizing copy number variation using proximity-litigation sequencing
|
|
GB201618485D0
(en)
|
2016-11-02 |
2016-12-14 |
Ucl Business Plc |
Method of detecting tumour recurrence
|
|
US10011870B2
(en)
|
2016-12-07 |
2018-07-03 |
Natera, Inc. |
Compositions and methods for identifying nucleic acid molecules
|
|
CA3194557A1
(en)
|
2017-01-20 |
2018-07-26 |
Sequenom, Inc. |
Sequencing adapter manufacture and use
|
|
EP3571614A1
(en)
|
2017-01-20 |
2019-11-27 |
Sequenom, Inc. |
Methods for non-invasive assessment of copy number alterations
|
|
EP3571615B1
(en)
|
2017-01-20 |
2024-01-24 |
Sequenom, Inc. |
Methods for non-invasive assessment of genetic alterations
|
|
EP3574424A1
(en)
|
2017-01-24 |
2019-12-04 |
Sequenom, Inc. |
Methods and processes for assessment of genetic variations
|
|
CA3049139A1
(en)
|
2017-02-21 |
2018-08-30 |
Natera, Inc. |
Compositions, methods, and kits for isolating nucleic acids
|
|
US12421550B2
(en)
|
2017-03-17 |
2025-09-23 |
Sequenom, Inc. |
Methods and processes for assessment of genetic mosaicism
|
|
US12084720B2
(en)
|
2017-12-14 |
2024-09-10 |
Natera, Inc. |
Assessing graft suitability for transplantation
|
|
EP3737774B1
(en)
|
2018-01-12 |
2024-12-25 |
Claret Bioscience, LLC |
Method for analyzing nucleic acid
|
|
US12398389B2
(en)
|
2018-02-15 |
2025-08-26 |
Natera, Inc. |
Methods for isolating nucleic acids with size selection
|
|
WO2019200228A1
(en)
|
2018-04-14 |
2019-10-17 |
Natera, Inc. |
Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
|
|
WO2019236726A1
(en)
|
2018-06-06 |
2019-12-12 |
The Regents Of The University Of California |
Methods of producing nucleic acid libraries and compositions and kits for practicing same
|
|
US12234509B2
(en)
|
2018-07-03 |
2025-02-25 |
Natera, Inc. |
Methods for detection of donor-derived cell-free DNA
|
|
EP4538390A3
(en)
|
2019-04-05 |
2025-07-09 |
Claret Bioscience, LLC |
Methods and compositions for analyzing nucleic acid
|
|
CN114144531A
(en)
*
|
2019-05-23 |
2022-03-04 |
美国分子实验室公司 |
Method for detecting rare DNA sequences in fecal samples
|
|
US12305235B2
(en)
|
2019-06-06 |
2025-05-20 |
Natera, Inc. |
Methods for detecting immune cell DNA and monitoring immune system
|
|
AU2020363787A1
(en)
|
2019-10-09 |
2022-04-21 |
Claret Bioscience, Llc |
Methods and compositions for analyzing nucleic acid
|
|
EP4052259A1
(en)
|
2019-10-31 |
2022-09-07 |
Sequenom, Inc. |
Application of mosaicism ratio in multifetal gestations and personalized risk assessment
|
|
JP7802707B2
(en)
|
2020-06-24 |
2026-01-20 |
クラレット バイオサイエンス, エルエルシー |
Methods and compositions for analyzing nucleic acids
|
|
WO2022076574A1
(en)
|
2020-10-08 |
2022-04-14 |
Claret Bioscience, Llc |
Methods and compositions for analyzing nucleic acid
|
|
WO2024186778A1
(en)
|
2023-03-03 |
2024-09-12 |
Laboratory Corporation Of America Holdings |
Methods and systems for positive cfdna screening on genetic variations using mosaicism ratio
|
|
AU2024271681A1
(en)
|
2023-05-15 |
2025-09-18 |
Laboratory Corporation Of America Holdings |
Machine-learning approaches to pan-cancer screening in whole genome sequencing
|